VIVA AND THE VEINS 2019: Dr. Suresh Vedantham to receive VEIN Award; abstracts now being accepted
Suresh Vedantham, MD, past president of the Society of Interventional Radiology, will receive the 2019 Venous Educator, Innovator, and National Statesman Award (VEIN AWARD) during VIVA and The VEINS2019 conference Nov. 4-7 at the Wynn Las Vegas.
Dr. Vedantham is a professor of Radiology & Surgery at the Mallinckrodt Institute of Radiology at the Washington University School of Medicine in St. Louis. In addition, he is an experienced interventional radiologist who specializes in the delivery and clinical investigation of image-guided therapies for venous thromboembolism (VTE).
He also has a clinical practice in which he sees patients with complex vascular/thrombotic disorders who are referred to him locally, nationally and internationally for treatment that often includes innovative, image-guided procedures.
At Washington University, Dr. Vedantham serves as assistant dean for Clinical Research and adviser to the vice chancellor for research.
Nationally, Dr. Vedantham is recognized as an outstanding and highly collaborative leader of complex multidisciplinary endeavors aimed at enhancing the care of venous disease. He has served as the 2017-2018 president of the Society of Interventional Radiology and also as an executive board member for the American Venous Forum, American College of Phlebology, American Board of Phlebology, Vascular Disease Foundation, and Venous Disease Coalition.
Dr. Vedantham has devoted his career to the development of high-quality evidence with which to guide venous patient care. Of particular significance, he serves as national principal investigator of the landmark, multicenter, NIH-sponsored ATTRACT and C-TRACT Trials that are defining the appropriate role of catheter-based endovascular therapy in the management of DVT and its late complications.
THE LIVE AWARD
The Leader In EndoVascular Education Award goes to Bruce H. Gray, DO, director of endovascular services at Prisma Health in Greenville, South Carolina, and a professor of surgery and vascular medicine at the University of South Carolina School of Medicine in Greenville.
The award recognizes those vascular specialists who have dedicated their professional careers to educating students, postgraduate trainees, and peers in all aspects of vascular medicine and intervention.
Dr. Gray is an early adopter of new devices for carotid, AAA, PAD, and VTE treatment, and has participated in numerous clinical trials involving all of these areas.
He previously served on the board of the Society for Vascular Medicine, and has also served as the director of the American Board of Vascular Medicine since its inception in 2003.
The ATLAS AWARD
Christopher J. White, MD, professor and chairman of the Department of Medicine for the Ochsner Clinical School in in New Orleans, Louisiana, was awarded the A Teacher, Leader, And Scholar Award (ATLAS), which celebrates the career and impact of physicians who have distinguished themselves as scholars and leaders in their respective vascular fields.
The ATLAS Award recognizes those who have committed their careers to advancing the care of patients with vascular disorders, and they have taught countless numbers of physicians techniques to expand care across the United States and the world.
Dr. White was graduated AOA from Case Western Reserve Medical School in Cleveland, Ohio, in 1978 and completed his training in medicine and cardiology at Letterman Army Medical Center (LAMC) in San Francisco (1978-1983). After completing his active duty military service in 1988, he joined Ochsner Clinic in New Orleans. In 1994, Dr. White moved to Glasgow, Scotland, for HealthCare International (HCI), and in 1997, returned to Ochsner as chairman of the Department of Cardiology.
In addition to his chairman duties at Ochsner, he also holds the positions of medical director for Value-Based Care and system chairman of Cardiovascular Diseases for the 14-hospital Ochsner Health System.
THE VASCULAR CAREER
The VIVA and LINC collaborative Vascular Career Advancement Awards, which recognize young physicians who show promise as potential leaders in the vascular field, will go to Steven Kum, MD, and Paraq J. Patel, MD.
<bold>Steven Kum, MD
Dr. Kum, who is a pioneer in percutaneous deep arterialization for no-option critical limb ischemia, maintains his practice at Mount Elizabeth Novena Hospital in Singapore.
Since 2015, Dr. Kum has been the director of vascular surgery at Changi General Hospital in Singapore, and he was subsequently appointed as a visiting consultant in 2019.
He is also a faculty member for General Surgical Residents for Singhealth, and regularly proctors physicians in endovascular procedures in Europe and Asia. He is regularly invited to several regional and international meetings and is part of the organizing committee of LINC and VERVE.
He has a keen interest in clinical research revolving around diabetic limb salvage, and has authored or co-authored numerous papers relating to percutaneous deep arterialization for no-option critical limb ischemia.
Parag J. Patel, MD
Dr. Patel is an associate professor of Radiology and Surgery in the Division of Vascular & Interventional Radiology at the Medical College of Wisconsin and Froedtert Memorial Lutheran Hospital in Milwaukee, Wisconsin.
His clinical and research interests include evaluation and endovascular treatment of peripheral vascular disease, complex aortic disease, venous disease as well as embolization therapies.
In 2008, Dr. Patel joined the faculty at Medical College of Wisconsin (MCW), which has a longstanding well-developed multidisciplinary vascular practice and vascular training program with interventional radiology and vascular surgery fellows.
He has been involved with the education and mentorship of trainees, medical students, residents and fellows since arriving at MCW. He is the program director for the VIR Fellowship and IR Residency training programs at MCW.
ABSTRACTS BEING ACCEPTED
Abstract submissions are now being accepted for VIVA19 Late-Breaking Clinical Trials, with an Aug. 22 deadline looming. Notification of acceptance will be sent the week of Sept. 9.
Accepted clinical trials will be presented in the Global Theater on Nov. 5-6. Presentations will be 9 minutes each and will be followed by a Q&A with questions posed by an expert panel and the audience.
Abstract submissions should address areas of endovascular medicine and report the results of clinical studies, basic science investigations or pre-clinical studies. VTN